Skip to main content
. Author manuscript; available in PMC: 2013 May 30.
Published in final edited form as: ChemMedChem. 2011 Jul 14;6(9):1739–1745. doi: 10.1002/cmdc.201100113

Figure 2.

Figure 2

The antinociceptive activity of the cyclic tetrapeptides was assessed in vivo following i.c.v. administration in the 55°C warm-water tail-withdrawal assay in C57Bl/6J mice. All points represent antinociception at peak response, which was 20 min (for 4), 30 min (for peptides 1, 2 and 5) or 40 min (peptide 3). All points represent average % antinociception ± SEM from 7-8 mice. Data for 1 from reference [12a].